Glanbia to Distribute CapsiAtra in US

Glanbia Nutritionals announced it has signed an agreement to distribute Ajinomoto's CapsiAtra in the United States.

June 9, 2014

1 Min Read
Glanbia to Distribute CapsiAtra in US

CARLSBAD, Calif.—Glanbia Nutritionals announced it will be the exlusive U.S. distributor of CapsiAtra, a dihydrocapsiate compound from Ajinomoto.

CapsiAtra, a compound naturally found in CH-19 sweet peppers, holds clinical benefits in weight management, endurance and metabolism. The product provides a new weight management and sports nutrition solution for easy inclusion in ready-to-mix, capsule and tablet applications. In addition to numerous human clinical trials, CapsiAtra also received a letter of no objection from the U.S. Food and Drug Administration (FDA) in regards to its GRAS (generally recognized as safe) safety dossier.

Glanbia and Ajinomoto will work closely to introduce CapsiAtra into innovative and novel applications, resulting in CapsiAtra’s inclusion in a variety of food and beverage weight management products and sports nutrition supplements, with the goal of co-expanding the businesses further.

Check out INSIDER's Sports Nutrition Digital Issue, "Making the Cut," for more information on sports nutrition ingredients to take consumers beyond the burn.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like